Menu
Recruiting NCT05716737

Exploring Radiotherapy of Temporomandibular Joint Arthritis

No phase Interventional Arthritis of Temporomandibular Joint

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Irradiation.
Who it may be relevant to
Registry conditions: Arthritis of Temporomandibular Joint. Basic parameters: 50 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Austria
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

With this pilot study, the acute side effects and potential pain relieve after radiotherapy (RT) of the temporomandibular joint (TMJ) are prospectively recorded. For this purpose, the symptoms of the jaw joint arthrosis/arthritis are recorded using a symptom-oriented questionnaire and the numeric rating scale for pain assessment. Furthermore, it is examined whether the irradiation is feasible.

Interventions

  • Radiation Irradiation
    3 Gy in 6 fractions to the TMJ, every other day, LINAC based

Primary outcome measures

  • therapeutic effect [Time frame: Before, directly after treatment and after 3, 6 9 and 12 months]
Secondary outcome measures (1)
  • Other temporomandibular joint conditions [Time frame: Before, directly after treatment and after 3, 6 9 and 12 months]

Eligibility criteria

Inclusion criteria

  • TMJ arthritis
  • diagnosed by a surgeon for oral and maxillofacial surgery or a dentist

Exclusion criteria

  • Previous irradiation in the TMJ area
  • Age below 50 years

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Austria · 1 center
  • Medical University of Vienna — Vienna

Identifiers

NCT: NCT05716737 · TMJRT1107/2023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗